Advisory Research’s Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share ASZ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-392,967
Closed -$413K 421
2021
Q3
$413K Buy
392,967
+137,347
+54% +$153K 0.03% 265
2021
Q2
$320K Buy
+255,620
New +$280K 0.02% 301

Other funds holding ASZ.WS

Advisory Research's ASZ.WS Position: Q4 2021 in Review

Advisory Research sold out of Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (ASZ.WS) in Q4 2021, closing a stake of 392,967 shares — an estimated $413K sold.

Advisory Research first reported a position in ASZ.WS in Q2 2021 and held it in 2 quarters. The position peaked at $413K in Q3 2021. 85 funds tracked by Wall St. Rank hold ASZ.WS as of Q4 2021.

  • Advisory Research reported no remaining Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position as of Q4 2021 after selling out during the quarter.
  • Advisory Research sold 392,967 Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share shares in Q4 2021, an estimated $413K.
  • Advisory Research first reported a position in Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q2 2021 and held it in 2 quarters.
  • Advisory Research's Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $413K in Q3 2021.
  • 85 funds tracked by Wall St. Rank held Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q4 2021.

Based on Advisory Research's 13F filing for Q4 2021, filed 11 Feb 2022.